Search

everythinglearnresearchcommunity

for

Search:↓

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Apremilast improved symptoms in patients with severe skin conditions.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

MK-5108 is safe and shows potential against tumors, especially alone.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Epimedium extract helps increase skin pigmentation and could be a new treatment for conditions with reduced pigmentation.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Upadacitinib effectively treated severe hair loss in a child.

Using finasteride with TIP extends time off period for prostate cancer patients.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.